The gene for May-Hegglin anomaly localizes to a <1-Mb region on chromosome 22q12.3-13.1 - PubMed (original) (raw)
. 2000 Apr;66(4):1449-54.
doi: 10.1086/302873. Epub 2000 Mar 17.
Affiliations
- PMID: 10739770
- PMCID: PMC1288213
- DOI: 10.1086/302873
The gene for May-Hegglin anomaly localizes to a <1-Mb region on chromosome 22q12.3-13.1
J A Martignetti et al. Am J Hum Genet. 2000 Apr.
Abstract
The May-Hegglin anomaly (MHA) is an autosomal dominant platelet disorder of unknown etiology. It is characterized by thrombocytopenia, giant platelets, and leukocyte inclusion bodies, and affected heterozygotes are predisposed to bleeding episodes. The MHA gene has recently been localized, by means of linkage analysis, to a 13.6-cM region on chromosome 22, and the complete chromosome 22 sequence has been reported. We recently performed a genome scan for the MHA gene in 29 members of a large, multigenerational Italian family, and we now confirm that the MHA locus is on chromosome 22q12. 3-13.1. The maximal two-point LOD score of 4.50 was achieved with the use of marker D22S283, at a recombination fraction of.05. Haplotype analysis narrowed the MHA critical region to 6.6 cM between markers D22S683 and D22S1177. It is of note that the chromosome 22 sequence allowed all markers to be ordered correctly, identified all the candidate genes and predicted genes, and specifically determined the physical size of the MHA region to be 0. 7 Mb. These results significantly narrow the region in which the MHA gene is located, and they represent the first use of chromosome 22 data to positionally clone a disease gene.
Figures
Figure 1
Pedigree of the Italian kindred with MHA. This family was previously described elsewhere (Bizzaro 1997), and we have herein updated its members' disease status. Family members in the present study are numbered. Blackened symbols denote affected individuals; unblackened symbols denote unaffected individuals. Affected individual V.3 (gray-shaded circle) also has von Willebrand disease.
Figure 2
Haplotypes of the kindred with MHA. Twelve markers (D22S345, D22S277, D22S1142, D22S683, D22S283, D22S1177, IL2RB, D22S445, D22S272, D22S284, D22S423, and D22S444) from within and flanking the linkage region are shown. Family numbers and individual numbers are the same as those in figure 1. Affected individuals are underlined with a blackened bar; unaffected individuals are underlined with an unblackened bar. Spouses are shown to determine phase.
Figure 3
Chromosome 22 ideogram. The markers used in this study are shown with their relative locations and genetic distances, as previously defined (Broman et al. 1998), and with the actual physical distances based on chromosome 22 sequence data (Dunham et al. 1999).
Similar articles
- Autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly) is linked to chromosome 22q12-13.
Kelley MJ, Jawien W, Lin A, Hoffmeister K, Pugh EW, Doheny KF, Korczak JF. Kelley MJ, et al. Hum Genet. 2000 May;106(5):557-64. doi: 10.1007/s004390000294. Hum Genet. 2000. PMID: 10914687 - Mapping of a gene for May-Hegglin anomaly to chromosome 22q.
Kunishima S, Kojima T, Tanaka T, Kamiya T, Ozawa K, Nakamura Y, Saito H. Kunishima S, et al. Hum Genet. 1999 Nov;105(5):379-83. doi: 10.1007/s004390051119. Hum Genet. 1999. PMID: 10598801 - Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13.
Toren A, Rozenfeld-Granot G, Rocca B, Epstein CJ, Amariglio N, Laghi F, Landolfi R, Brok-Simoni F, Carlsson LE, Rechavi G, Greinacher A. Toren A, et al. Blood. 2000 Nov 15;96(10):3447-51. Blood. 2000. PMID: 11071640 - Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.
Kelley MJ, Jawien W, Ortel TL, Korczak JF. Kelley MJ, et al. Nat Genet. 2000 Sep;26(1):106-8. doi: 10.1038/79069. Nat Genet. 2000. PMID: 10973260 - Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13.
Toren A, Amariglio N, Rozenfeld-Granot G, Simon AJ, Brok-Simoni F, Pras E, Rechavi G. Toren A, et al. Am J Hum Genet. 1999 Dec;65(6):1711-7. doi: 10.1086/302654. Am J Hum Genet. 1999. PMID: 10577925 Free PMC article.
Cited by
- Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria.
Solis C, Aizencang GI, Astrin KH, Bishop DF, Desnick RJ. Solis C, et al. J Clin Invest. 2001 Mar;107(6):753-62. doi: 10.1172/JCI10642. J Clin Invest. 2001. PMID: 11254675 Free PMC article. - Unraveling MYH9-related disease: A case study on misdiagnosis with idiopathic thrombocytopenic purpura, confirmed through genetic.
Cai L, Chen S, Zhou Y, Yu H, Li Y, Bao A, Zhang J, Lv Q. Cai L, et al. Heliyon. 2024 Aug 13;10(18):e36203. doi: 10.1016/j.heliyon.2024.e36203. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39309903 Free PMC article. - Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, Savige J, Denison JC, Gregory MC, White JG, Barker DF, Greinacher A, Epstein CJ, Glucksman MJ, Martignetti JA. Heath KE, et al. Am J Hum Genet. 2001 Nov;69(5):1033-45. doi: 10.1086/324267. Epub 2001 Oct 4. Am J Hum Genet. 2001. PMID: 11590545 Free PMC article. - MYH-9 Related Platelet Disorders: Strategies for Management and Diagnosis.
Althaus K, Greinacher A. Althaus K, et al. Transfus Med Hemother. 2010;37(5):260-267. doi: 10.1159/000320335. Epub 2010 Sep 15. Transfus Med Hemother. 2010. PMID: 21113248 Free PMC article.
References
Electronic-Database Information
- Center for Medical Genetics, Marshfield Medical Research Foundation, http://www.marshmed.org/genetics/ (for the human genetic map)
- Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for MHA [MIM <155100>], Fechtner syndrome [MIM <153640>], and familial platelet disorder with associated myeloid malignancy [MIM <601399>])
References
- Adams P (1994) LABMAN and LINKMAN: a data management system specifically designed for genome searches of complex diseases. Genet Epidemiol 11:87–98 - PubMed
- Anderson MA, Gusella JF (1994) Use of cyclosporin A in establishing Epstein-Barr-virus–transformed human lymphoblastoid cell lines. In Vitro 20:856–858 - PubMed
- Bizzaro N (1997) L'anomalia di May-Hegglin: una rara causa di piastrinopenia congenita: descrizione della malattia e di un vasto gruppo familiare del Veneto orientale. Med Lab 5:165–171
- Bizzaro N (1999) May-Hegglin anomaly and uncomplicated vaginal delivery: a report of 41 cases. Am J Obstet Gynecol 181:226–227 - PubMed
Publication types
MeSH terms
Grants and funding
- 5 P30 HD28822/HD/NICHD NIH HHS/United States
- 5 MO1 RR00071/RR/NCRR NIH HHS/United States
- M01 RR000071/RR/NCRR NIH HHS/United States
- 5 R37 DK34045/DK/NIDDK NIH HHS/United States
- R37 DK034045/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous